Ben is a Partner in ZS’s Associates East Coast region focused on BD, Pipeline and Launch Strategy. ZS is a biopharma focused management consulting firm with more than 5,000 employees across twenty-three global offices. In a typical year, ZS supports more than 85% of oncology product launches and new indication launches. Ben has more than twenty years of experience helping clients with the strategic choices and challenges that intersect and cross the boundaries of commercial and product development organizations. Ben has particular experience in Franchise/TA strategy, Business Development Opportunity Identification and Assessment, New Product Launch, and Pipeline Asset strategy. Ben is a leading expert in emerging pharma "first launch" and the majority of his work is in oncology. Ben has spoken at industry conferences and written on topics related to launch, Franchise/TA Strategy and Business Development.